Search details
1.
The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2.
J Med Genet
; 60(5): 440-449, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36319079
2.
The DNA damage response in advanced ovarian cancer: functional analysis combined with machine learning identifies signatures that correlate with chemotherapy sensitivity and patient outcome.
Br J Cancer
; 128(9): 1765-1776, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36810910
3.
Optimization of polygenic risk scores in BRCA1/2 pathogenic variant heterozygotes in epithelial ovarian cancer.
Genet Med
; 25(9): 100898, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37212253
4.
Uptake and efficacy of bilateral risk reducing surgery in unaffected female BRCA1 and BRCA2 carriers.
J Med Genet
; 59(2): 133-140, 2022 02.
Article
in English
| MEDLINE | ID: mdl-33568438
5.
BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing?
Br J Cancer
; 127(1): 163-167, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35260807
6.
c-MET/VEGFR-2 co-localisation impacts on survival following bevacizumab therapy in epithelial ovarian cancer: an exploratory biomarker study of the phase 3 ICON7 trial.
BMC Med
; 20(1): 59, 2022 02 11.
Article
in English
| MEDLINE | ID: mdl-35144591
7.
p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial.
Mod Pathol
; 35(10): 1475-1483, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35752743
8.
High detection rate from genetic testing in BRCA-negative women with familial epithelial ovarian cancer.
Genet Med
; 24(12): 2578-2586, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36169650
9.
Dominant-negative pathogenic variant BRIP1 c.1045G>C is a high-risk allele for non-mucinous epithelial ovarian cancer: A case-control study.
Clin Genet
; 101(1): 48-54, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34585738
10.
Cervical cancer and COVID-an assessment of the initial effect of the pandemic and subsequent projection of impact for women in England: A cohort study.
BJOG
; 129(7): 1133-1139, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35015334
11.
Quality of life from cytoreductive surgery in advanced ovarian cancer: Investigating the association between disease burden and surgical complexity in the international, prospective, SOCQER-2 cohort study.
BJOG
; 129(7): 1122-1132, 2022 06.
Article
in English
| MEDLINE | ID: mdl-34865316
12.
Comparison of two questionnaires to diagnose obstructive defecation syndrome during pregnancy and post-natally.
Int Urogynecol J
; 33(11): 3129-3136, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35267060
13.
Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levels.
Int J Cancer
; 148(5): 1155-1163, 2021 03 01.
Article
in English
| MEDLINE | ID: mdl-33152107
14.
Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study.
BMC Cancer
; 21(1): 378, 2021 Apr 08.
Article
in English
| MEDLINE | ID: mdl-33832445
15.
A phase 2 study of anastrozole in patients with oestrogen receptor and/progesterone receptor positive recurrent/metastatic granulosa cell tumours/sex-cord stromal tumours of the ovary: The PARAGON/ANZGOG 0903 trial.
Gynecol Oncol
; 163(1): 72-78, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34412908
16.
British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom.
Int J Gynecol Cancer
; 31(2): 272-278, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33468564
17.
A Prospective Study to Identify Rates of SARS-CoV-2 Virus in the Peritoneum and Lower Genital Tract of Patients Having Surgery: An Observational Study.
J Minim Invasive Gynecol
; 28(9): 1633-1636, 2021 09.
Article
in English
| MEDLINE | ID: mdl-33582377
18.
Epithelial ovarian cancer risk: A review of the current genetic landscape.
Clin Genet
; 97(1): 54-63, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31099061
19.
First-Line Management of Advanced High-Grade Serous Ovarian Cancer.
Curr Oncol Rep
; 22(6): 64, 2020 06 04.
Article
in English
| MEDLINE | ID: mdl-32494876
20.
Prevalence of germline pathogenic BRCA1/2 variants in sequential epithelial ovarian cancer cases.
J Med Genet
; 56(5): 301-307, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30683677